Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

3.750 USD -0.080 (-2.09%)
Official Closing Price Updated: 7:57 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Genprex Inc

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Oncology Franchise via Exclusive Worldwide Patent and Technology License Agreement
From InvestorBrandNetwork
Biotech Brief: Global Market For Cancer Drug Candidates Could Exceed US$220 Billion By 2025
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotech Brief: Global Market for Cancer Drug Candidates Could Exceed US$220 Billion by 2025
Financialnewsmedia.com News Commentary 
From PR Newswire
Genprex Enters Into Exclusive Worldwide Patent and Technology License Agreement for Combination of its TUSC2 Gene Therapy with Immunotherapies
Genprex Signs Exclusive Worldwide License Agreement with MD Anderson Cancer Center 
From Business Wire News Releases
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Issues Shareholder Letter Highlighting Oncoprex(TM) Progress, License Agreement for a Diabetes Drug Candidate and Other Achievements
From InvestorBrandNetwork
Genprex Issues April 2020 Shareholder Letter
Genprex issues a letter to shareholders, providing corporate and clinical updates. 
From Business Wire News Releases
First Week of December 18th Options Trading For Genprex (GNPX)
Investors in Genprex Inc (GNPX) saw new options begin trading this week, for the December 18th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time... 
Tags Stocks
From Market News Video
3 Penny Stocks To Watch With “Strong Buy” Ratings
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Appoints Accomplished Executive Shannon Inman to Drive Launch of Key Clinical Trials
From InvestorBrandNetwork
Genprex Appoints Shannon Inman as Vice President of Global Clinical Operations
Genprex hires new Vice President of Global Clinical Operations. 
From Business Wire News Releases
10 Biotech Winners And Losers In Q1
The quarter was brutal to say the least for most asset classes amid the coronavirus (COVID-19) pandemic. The S&P 500 Index was down ... 
Tags GNPX MIST IBB
From Benzinga
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Strategic Board Appointments of Three Biotechnology and Healthcare Industry Leaders
From InvestorBrandNetwork
Genprex Bolsters Board of Directors, Appoints Three Biotechnology and Healthcare Industry Leaders
Genprex adds three new members to its Board of Directors. 
From Business Wire News Releases
18 Healthcare Stocks Moving In Tuesday's Pre-Market Session
Gainers • Novavax, Inc. (NASDAQ:NVAX) stock rose 41.26% to $15.20 during Tuesday's pre-market session. The most recent ... 
Tags TLRY CODX AYTU
From Benzinga
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Leadership Team with Appointment of Accomplished Life Science Executives
From InvestorBrandNetwork
Genprex Strengthens Leadership Team with the Appointment of Two Accomplished Life Science Executives
Genprex adds two accomplished life science leaders to its executive team. 
From Business Wire News Releases
20 Healthcare Stocks Moving In Monday's Session
Gainers Spherix, Inc. (NASDAQ:SPEX) stock moved upwards by 80.49% to $2.96 during Monday's regular session. Cocrystal ... 
Tags CASI CODX DRAD
From Benzinga
NetworkNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) Lead Researcher Behind its Diabetes Gene Therapy Featured in New Video Interview
From InvestorBrandNetwork
Lead Researcher Behind Genprex’s Diabetes Gene Therapy Featured in New Video Interview
Genprex's newly licensed gene therapy for diabetes explained by lead researcher in new video. 
From Business Wire News Releases
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) CEO Presenting at the 2020 LD Micro Virtual Conference
From InvestorBrandNetwork
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) to Present at the Third Annual LD Micro Virtual Conference
From InvestorBrandNetwork
Prognosis for Treatment of Glioblastoma Multiforme Expected to Impact Market Growth for Drug Makers
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Prognosis for Treatment of Glioblastoma Multiforme Expected to Impact Market Growth for Drug Makers
Financialnewsmedia.com News Commentary 
From PR Newswire
Genprex to Present at the 2020 LD Micro Virtual Conference
Genprex's CEO will present at the LD Micro Virtual Conference on March 4 at 1:40 p.m. EST. 
From Business Wire News Releases
108 Biggest Movers From Yesterday
Gainers China Pharma Holdings, Inc. (NASDAQ: CPHI) shares surged 100% to close at $1.14 on Monday after the company announced a ... 
Tags GH KNDI NCNA
From Benzinga
140 Biggest Movers From Friday
Gainers iBio, Inc. (NYSE: IBIO) shares surged 183.2% to close at $2.45 on Friday after jumping around 159% on Thursday. iBio ... 
Tags OPRX CLXT Movers
From Benzinga
50 Healthcare Stocks Moving In Friday's Pre-Market Session
Gainers Dynatronics, Inc.(NASDAQ: DYNT) shares increased by 239.4% to $4.09 during Friday's pre-market session. Ritter ... 
Tags ADXS PAVM NBRV
From Benzinga
Diagnosis: Volatility — Every Coronavirus-Related Stock That Was Halted For Trading Today
Wall Street has been sharply attuned to coronavirus news. In fact, the extreme volatility in the market brought 24 trading halts on ... 
Tags VXRT EQT Biotech
From Benzinga
100 Stocks Moving In Thursday's Mid-Day Session
Gainers Co-Diagnostics, Inc. (NASDAQ: CODX) shares jumped 107% to $18.42. Co-Diagnostics reported $4.2 million registered direct ... 
Tags KRA SAGE CVNA
From Benzinga
28 Healthcare Stocks Moving In Thursday's Pre-Market Session
Gainers Tonix Pharmaceuticals, Inc.(NASDAQ: TNXP) shares moved upwards by 73.3% to $1.56 during Thursday's pre-market ... 
Tags TDOC AHPI GLPG
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.